A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer ’s disease

Trial registrationClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered,https://classic.clinicaltrials.gov/ct2/show/NCT05821153
Source: Translational Neurodegeneration - Category: Neurology Source Type: research